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ABSTRACT
Background: Red cell distribution width to platelet ratio (RPR) is known to be associated with a degree of 
liver fibrosis in patients with hepatitis B. This study aims to compare the under curve area, sensitivity, specificity, 
positive predictive value, and negative predictive value between RPR and aspartate aminotransferase to platelet 
ratio index (APRI) score with degree of fibrosis.
Method: This study is a retrospective study, data taken from medical records of all chronic hepatitis B patients 
examined by Fibroscan at Sanglah General Hospital Denpasar, Bali from January 2016 to February 2018.
Results: Ninety eight (98) patients with chronic hepatitis B, 81 patients were recovered after exclusion of 
patients with chronic kidney disease, malignancy, and dengue haemorrhagic fever (DHF). In receiver operating 
characteristic (ROC) analysis, obtained area under the ROC curve (AUC) at RPR of 0.816, and at APRI score 
0.797. In RPR with cut off 0.066 the sensitivity was 76.9%, specificity 78.6%, PPV 79.5%, NPV 73.8%. While 
APRI score with cut off 0.85 got 69.2% sensitivity, specificity 76.2%, positive predictive value (PPV) 73.0%, and 
negative predictive value (NPV) 72.7%. According to Kappa test, we found kappa coefficient 0.653 (p < 0.05).
Conclusion: In predicting severe liver fibrosis in chronic hepatitis B patients, RPR is not inferior than APRI 
score, and may be used as a diagnostic marker, with 65.3% conformity.
Keywords: aspartate aminotransferase to platelet ratio index (APRI) score, red cell distribution width to 
platelet ratio (RPR), Chronic hepatitis B, liver fibrosis
ABSTRAK
Latar belakang: Red cell distribution width to platelet ratio (RPR) diketahui terkait dengan tingkat fibrosis 
hati pada pasien dengan hepatitis B. Penelitian ini bertujuan untuk membandingkan area under curve (AUC), 
sensitivitas, spesifisitas, nilai prediksi positif, dan nilai prediksi negatif antara RPR dan skor aspartate 
aminotransferase to platelet ratio index (APRI) dalam memprediksi derajat fibrosis.
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Metode: Penelitian ini merupakan studi retrospektif, data yang diambil dari rekam medis semua pasien 
hepatitis B kronis yang diperiksa menggunakan Fibroscan di Rumah Sakit Sanglah General Denpasar, Bali 
mulai Januari 2016 sampai Februari 2018.
Hasil: Sembilan puluh delapan (98) pasien dengan hepatitis B kronis, 81 pasien diambil sebagai sampel 
setelah dieksklusi pasien dengan penyakit ginjal kronis, keganasan, dan demam berdarah dengue (DBD). Dalam 
analisis receiver operating characteristic (ROC) diperoleh AUC di RPR sebesar 0,816, dan pada skor APRI 
0,797. Apabila RPR dipakai cut off 0,066 sensitivitasnya adalah 76,9%, spesifisitas 78,6%, positive predictive 
value (PPV) 79,5%, negative predictive value (NPV) 73,8%. Sedangkan skor APRI dengan cut off 0,85 mendapat 
sensitivitas 69,2%, spesifisitas 76,2%, PPV 73,0%, dan NPV 72,7%. Pada uji Kappa, kami menemukan koefisien 
kappa 0,653 (p < 0,05).
Simpulan: Dalam memprediksi fibrosis hati yang parah pada pasien hepatitis B kronis, RPR tidak lebih 
inferior dibandingkan skor APRI, dan dapat digunakan sebagai penanda diagnostik, dengan kesesuaian 65,3%.
Kata kunci: skor aspartate aminotransferase to platelet ratio index (APRI), red cell distribution width to 
platelet ratio (RPR), hepatitis B kronis, fibrosis hati
specificity.7 In terms of cost, RPR is cheaper than 
APRI because it only requires one panel of routine 
blood examination. However, its performance when 
compared with APRI is still not much studied. In this 
study we will investigate the accuracy of diagnosis of 
liver fibrosis by using RPR and APRI and compare 
the two methods.
METHOD
This study was conducted retrospectively, from 
January 2016 to February 2018. Data were taken 
from medical record and Fibroscan register Sanglah 
General Hospital Bali which fulfilled the inclusion 
criteria ; all chronic hepatitis B patients aged > 12 
years with HBsAg positivity for 6 months or more, 
who came to Sanglah General Hospital and performed 
Fibroscan examination. Exclusion criteria in this study 
were the presence of HIV and hepatitis C coinfection, 
hepatocellular carcinoma (HCC), chronic renal disease, 
idiopathic thrombocytopenia purpura and dengue 
hemorrhagic fever.
In subjects meeting the inclusion criteria, RPR and 
APRI were evaluated with medical record tracking, 
and compared with Fibroscan examination results. 
RDW, platelet, aspartate aminotransferase (AST), and 
Fibroscan data were taken at the same or the longest 
period within 30 days. RPR is calculated by the formula 
= RDW(%)/Plt(109/L), whereas APRI = AST(/ULN) 
x 100/Plt(109/L). Fibroscan examination results were 
classified into 2 groups; mild-moderate fibrosis (metavir 
F0-2) and severe fibrosis (metavir F3-4). Then the data 
was analysed using receiver operating characteristic 
(ROC) curve to determine the area under the ROC curve 
(AUC), cut-off point, sensitivity, specificity, positive 
INTRODUCTION
Liver fibrosis is a chronic complication of hepatitis 
B infection. This condition remains silent until the 
patient falls to decompensated cirrhosis, which is 
the third leading cause of death after cardiovascular 
disease and cancer.1 Early detection is very important 
in the management of chronic hepatitis B, in order 
to determine therapy and also improves prognosis.2 
Histopathological examination of liver tissue is still a 
gold standard of the diagnosis of fibrosis and cirrhosis 
of the liver. However, this method is an invasive 
procedure and tends to be abandoned lately. Various 
non-invasive methods were developed as an attempt 
to replace liver biopsy tests, such as ultrasonography, 
transient elastography (TE), and biochemical markers, 
such as aspartate aminotransferase to platelet ratio 
index (APRI), gamma glutamyl transpeptidase to 
platelet ratio (GPR), and fibrosis-4 (FIB-4).3
According to the World Health Organization 
(WHO) guidelines in 2015, APRI has recommended as 
a non-invasive method to predict liver cirrhosis in areas 
with limited resources, whereas TE is recommended 
in areas with adequate facilities.2 APRI with a value of 
≥ 2 has been validated to detect liver cirrhosis. While 
TE is an examination using low frequency shear waves 
to assess liver stiffness.4,5 Red cell distribution width 
to platelet ratio (RPR) is currently under investigation 
because it is thought to be associated with a degree of 
liver fibrosis. The RPR was first proposed by Chen et 
al in 2013, a prediction model consisting of red cell 
distribution width (RDW) and platelet components 
known to be associated with a degree of liver fibrosis 
in a multivariate analysis.6 In another study, RPR can 
also predict liver fibrosis in Primary Biliary Cirrhosis 
populations with 46.7% sensitivity and 96.4% 
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predictive value (PPV), and negative predictive value 
(NPV) between APRI and RPR. There were also Kappa 
tests to determine the suitability between RPR and APRI 
in diagnosing severe fibrosis. Analysis was performed 
using SPSS Statistics version 23 (IBM Corporation, 
New York, NY).
RESULTS
In January 2016 up to February 2018 there 
were 98 chronic hepatitis B patients examined by 
Fibroscan. After exclusion of patients with chronic 
kidney disease, malignancy, and DHF, 81 samples 
were obtained in the study. The subjects consisted 
of 59 men and 22 women, aged 15-72 years with an 
average age of 43 years. The results of Fibroscan 
examination were 42 persons with mild-moderate 
fibrosis (metavir F0-2) and 39 severe fibrosis (metavir 
F3-4). The average RDW value of the study subjects 
was 13.78% ± 2.69. The average platelet count was 
187.429/mm³ ± 101.601. The ratio of RDW/platelet 
obtained an average of 0.16 ± 0.45.
Table 1. Characteristic of the subjects
Variables n = 81
Sex, n (%)
   Male 
   Female
59 (72,8)
22 (27,2)
Age (years) 43 ± 12,36*
Fibroscan result, n (%)
  F0
  F1
  F2
  F3
  F4
23 (28,4)
15 (18,5)
4 (4,9)
4 (4,9)
35 (43,2)
Aspartate aminotransferase (AST) 41,70 (8.80 – 532,10)**
Platelet 187,43 ± 101,60*
Red cell distribution width (RDW) 12,76 (11,22 – 24,92)**
AST to Platelet Ratio Index (APRI) score 0,72 (0,1 – 28,6)**
RDW to platelet ratio (RPR) 0,06 (0,03 – 4,09)**
*mean, SD; **median, minimum-maximum
In ROC analysis in Figure 1, we can see that both 
RPR and APRI curves are on the left side of the 
diagonal line. The AUC of RPR in predicting severe 
fibrosis was found 0,816 (p < 0,05) which tends 
to be no different than APRI with AUC 0,797 (p < 
0.05) (Figure 2). In RPR with the cut off 0.063 the 
sensitivity was 76.9%, specificity 78.6%, PPV 79.5%, 
NPV 73.8% for predicting severe liver fibrosis. While 
APRI with the cut off 0.85 obtained 69.2% sensitivity, 
specificity 76.2%, PPV 73.0%, and NPV 72.7%. 
Furthermore, in Kappa test, the coefficient of Kappa 
0.653 (p < 0.05) as shown in Figure 3, which means 
the match between RPR and APRI in predicting 
severe fibrosis is 65.3%. 
DISCUSSION
Some non-invasive markers to assess the degree of 
liver fibrosis in chronic hepatitis B patients are widely 
proposed and validated.3 This is due to the importance 
of in the use of non-invasive blood markers such as 
APRI, GRP, FIB-4, or RPR for determining treatment 
and prognosis in limited area setting. APRI was first 
proposed by Wai et al in 2003 to predict liver fibrosis 
and cirrhosis in chronic hepatitis C patients.8 This 
simple examination is preferred because it is cheap 
and easy to apply especially as an early screening of 
cirrhosis in areas with limited resources. Then several 
studies on its use in chronic hepatitis B infection were 
done, until finally APRI had recommended its use by 
WHO in 2015. However, when compared with other 
non-invasive markers, APRI is more inferior than the 
markers FIB-4 and GPR.3
A study conducted by Chen et al in 2013 stated 
that RDW and platelet levels correlated with the 
degree of liver fibrosis in chronic hepatitis B patients, 
which then made a prediction model of RPR.6 In 
another study, there was also an increase in RDW in 
chronic renal disease, systemic lupus erythematosus 
(LES), and acute myocardial infarction.9 RDW also 
plays a prognostic factor, which the increase in 
RDW is positively correlated with cirrhosis based on 
Child-Pugh score and increased mortality of patients 
with coronary heart disease, with an unexplained 
mechanism.10,11
Figure 1. Receiver operating characteristic (ROC) curve
Several previous studies have suggested that RPR 
is superior to APRI in predicting significant liver 
fibrosis.3,6 Comparing to FIB-4 and GPR, RPR has 
a comparable AUC in predicting significant fibrosis 
(metavir F ≥ 2).3 While in this study obtained AUC 
of RPR and APRI did not significantly different 
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in predicting liver fibrosis in chronic hepatitis B 
patients. The AUC stated that both APRI and RPR 
have moderate accuracy in diagnosing severe fibrosis 
(metavir F3-4). So these two predictive models can 
both be used as a diagnostic tool. 
The differences of sample characteristics, differences 
of cut off used, and some weaknesses in this study 
may be the cause of different results obtained from 
previous research. The weaknesses in this study were 
retrospective study design, no direct interviews on the 
subjects, and no histopathological examination of the 
liver as a gold standard diagnosis of liver fibrosis which 
allowed less representative results. Evaluation based on 
HBV DNA and HBeAg virus counts was also not done 
because of the limited data available. However, RPR is 
comparable to APRI in predicting severe liver fibrosis 
in chronic hepatitis B patients and may be used as a 
non-invasive marker with moderate accuracy.
CONCLUSION
In predicting severe liver fibrosis in chronic 
hepatitis B patients, RPR is not less inferior than APRI 
and can be used as one of the non-invasive methods in 
areas with limited resources.
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Figure 3. Kappa test result for RDW platelet ratio (RPR) and aminotransferase to platelet ratio index (APRI)
Figure 2. Area under the curve (AUC)
Test result variable (s) Area Std.errora Asymptotic Sig.b
Asymptotic 95% Confidence 
interval
Lower bound Upper bound
Red cell distribution width (RDW) to platelet ratio .816 .050 .000 .717 .914
AST to platelet ratio index (APRI) score .797 .049 .000 .702 .893
Value Standard errora Approximate Tb Significance
Measure of agreement Kappa .653 .084 5.886 .000
N of valid cases 81
aNot assuming the null hypothesis
bUsing the asymptotic standard error assuming the null hypothesis
